R&D Pipeline
Guided by innovation and internationalization, Fosun Pharma increases its investment in R&D and the introduction of scientific research personnel, enriches its innovative product pipelines, improves its R&D and clinical trial capacities for new drugs, and speeds up the R&D and transformation of innovative technologies and products through diverse and multi-level cooperation models, such as independent R&D, co-development, in-licensing, and in-depth incubation.
Major Drug Projects under Development
As of December 31, 2021, Fosun Pharma had more than 240 projects under development, including innovator drugs, biosimilars, generic drugs and consistency evaluation.
-
- 27
- Self-developed small molecule innovator drugs
-
- 26
- Self-developed Innovative Biologics
-
- 11
- Licensed-in innovator drugs
-
- 14
- Self-developed biosimilars
-
- 25
- Consistency Evaluation Projects